Stressful presentations: Mild cold stress in laboratory mice influences phenotype of dendritic cells in naïve and tumor-bearing mice

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Kokolus, Kathleen M ^a   Spangler, Haley M ^a   Povinelli, Benjamin J ^a   Farren, Matthew R ^a   Lee, Kelvin P ^a   Repasky, Elizabeth A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Anti tumor immunity; Cold stress; Mouse models of cancer; Norepinephrine; Thermoregulation

Indexed keywords

CASPASE 3; CATECHOLAMINE; CD11B ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN; CLOBETASOL; DEXAMETHASONE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; ISOPRENALINE; MAGNETIC NANOPARTICLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATIDYLINOSITOL 3 KINASE; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY TEMPERATURE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; COLD STRESS; DENDRITIC CELL; DNA DAMAGE; HUMAN; HYPERTHERMIA; IMMUNE RESPONSE; NONHUMAN; PHYSIOLOGICAL STRESS; RADIOFREQUENCY ABLATION; T LYMPHOCYTE ACTIVATION;

EID: 84895541678     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00023     Document Type: Article

References (103)

1. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev (2002) 82(1):97-130. doi:10.1152/physrev.00023.2001.
2. Steinman RM. Lasker basic medical research award. Dendritic cells: versatile controllers of the immune system. Nat Med (2007) 13(10):1155-9. doi:10.1038/nm1643.
3. Lewis KL, Reizis B. Dendritic cells: arbiters of immunity and immunological tolerance. Cold Spring Harb Perspect Biol (2012) 4(8):a007401. doi:10.1101/cshperspect.a007401.
4. Reis e Sousa C. Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol (2004) 16:21-5. doi:10.1016/j.coi.2003.11.007.
5. Melief CJ. Cancer immunotherapy by dendritic cells. Immunity (2008) 29(3):372-83. doi:10.1016/j.immuni.2008.08.004.
6. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature (2007) 449(7161):419-26. doi:10.1038/nature06175.
7. Kalinski P, Edington H, Zeh HJ, Okada H, Butterfield LH, Kirkwood JM, et al. Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? Immunol Res (2011) 50(2-3):235-47. doi:10.1007/s12026-011-8224-z.
8. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 12(4):265-77. doi:10.1038/nrc3258.
9. Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity (2013) 39(1):38-48. doi:10.1016/j.immuni.2013.07.004.
10. Lin A, Schildknecht A, Nguyen LT, Ohashi PS. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett (2010) 127(2):77-84. doi:10.1016/j.imlet.2009.09.003.
11. Bevan MJ. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol (1976) 117(6):2233-8.
12. Granucci F, Lutz MB, Zanoni I. The nature of activatory and tolerogenic dendritic cell-derived signal 2. Front Immunol (2013) 4:198. doi:10.3389/fimmu.2013.00198.
13. Bakdash G, Sittig SP, van Dijk T, Figdor CG, de Vries IJ. The nature of activatory and tolerogenic dendritic cell-derived signal II. Front Immunol (2013) 4:53. doi:10.3389/fimmu.2013.00053.
14. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12(4):253-68. doi:10.1038/nri3175.
15. Apetoh L, Locher C, Ghiringhelli F, Kroemer G, Zitvogel L. Harnessing dendritic cells in cancer. Semin Immunol (2011) 23(1):42-9. doi:10.1016/j.smim.2011.01.003.
16. Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res (2013) 1(4):1-7. doi:10.1158/2326-6066.CIR-13-0118.
17. Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother (2006) 55(3):292-8. doi:10.1007/s00262-005-0689-y.
18. Ostberg JR, Gellin C, Patel R, Repasky EA. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J Immunol (2001) 167(5):2666-70.
19. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol (2009) 5(7):374-81. doi:10.1038/nrendo.2009.106.
20. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol (2003) 24(8):444-8. doi:10.1016/S1471-4906(03)00173-X.
21. Martin B, Ji S, Maudsley S, Mattson MP. Control laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A (2010) 107(14):6127-33. doi:10.1073/pnas.0912955107.
22. Dhabhar FS. Psychological stress and immunoprotection versus immunopathology in the skin. Clin Dermatol (2013) 31(1):18-30. doi:10.1016/j.clindermatol.2011.11.003.
23. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. Allergy Asthma Clin Immunol (2008) 4(1):2-11. doi:10.1186/1710-1492-4-1-2.
24. Viswanathan K, Daugherty C, Dhabhar FS. Stress as an endogenous adjuvant: augmentation of the immunization phase of cell-mediated immunity. Int Immunol (2005) 17(8):1059-69. doi:10.1093/intimm/dxh286.
25. Saint-Mezard P, Chavagnac C, Bosset S, Ionescu M, Peyron E, Kaiserlian D, et al. Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol (2003) 171(8):4073-80.
26. Kleyn CE, Schneider L, Saraceno R, Mantovani C, Richards HL, Fortune DG, et al. The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol (2008) 128(5):1273-9. doi:10.1038/sj.jid.5701144.
27. Hall JM, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME. Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract (2012) 2012:403908. doi:10.1155/2012/403908.
28. Abe M, Thomson AW. Influence of immunosuppressive drugs on dendritic cells. Transpl Immunol (2003) 11(3-4):357-65. doi:10.1016/S0966-3274(03)00050-9.
29. Elenkov IJ, Chrousos GP. Stress system-organization, physiology and immunoregulation. Neuroimmunomodulation (2006) 13(5-6):257-67. doi:10.1159/000104853.
30. Shodell M, Siegal FP. Corticosteroids depress IFN-alpha-producing plasmacytoid dendritic cells in human blood. J Allergy Clin Immunol (2001) 108(3):446-8. doi:10.1067/mai.2001.117928.
31. Ashworth J, Booker J, Breathnach SM. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br J Dermatol (1988) 118(4):457-69. doi:10.1111/j.1365-2133.1988.tb02453.x.
32. Furue M, Katz SI. Direct effects of glucocorticosteroids on epidermal Langerhans cells. J Invest Dermatol (1989) 92(3):342-7. doi:10.1111/1523-1747.ep12277165.
33. Halliday GM, Knight BA, Muller HK. Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants. Br J Dermatol (1986) 114(1):83-9. doi:10.1111/j.1365-2133.1986.tb02782.x.
34. Abe M, Thomson AW. Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin Immunol (2006) 118(2-3):300-6. doi:10.1016/j.clim.2005.09.019.
35. Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA, Muraille E, et al. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol (1995) 25(10):2818-24. doi:10.1002/eji.1830251016.
36. Cumberbatch M, Dearman RJ, Kimber I. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals. Immunopharmacology (1999) 41(3):235-43. doi:10.1016/S0162-3109(99)00037-5.
37. Pan J, Ju D, Wang Q, Zhang M, Xia D, Zhang L, et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett (2001) 76(3):153-61. doi:10.1016/S0165-2478(01)00183-3.
38. Matasic R, Dietz AB, Vuk-Pavlovic S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol (1999) 66(6):909-14.
39. Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol (2000) 30(4):1233-42. doi:10.1002/(SICI)1521-4141(200004)30:43.0.CO;2-F.
40. Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol (2002) 169(7):3555-64.
41. Salgado CG, Nakamura K, Sugaya M, Tada Y, Asahina A, Fukuda S, et al. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells1. J Invest Dermatol (1999) 113(6):1021-7. doi:10.1046/j.1523-1747.1999.00785.x.
42. Kitajima T, Ariizumi K, Bergstresser PR, Takashima A. A novel mechanism of glucocorticoid-induced immune suppression: the inhibition of T cell-mediated terminal maturation of a murine dendritic cell line. J Clin Invest (1996) 98(1):142-7. doi:10.1172/JCI118759.
43. Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol (2004) 122(3):673-84. doi:10.1111/j.0022-202X.2004.22324.x.
44. Seiffert K, Granstein RD. Neuroendocrine regulation of skin dendritic cells. Ann N Y Acad Sci (2006) 1088:195-206. doi:10.1196/annals.1366.011.
45. Panina-Bordignon P, Mazzeo D, Lucia PD, D'Ambrosio D, Lang R, Fabbri L, et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 100(6):1513-9. doi:10.1172/JCI119674.
46. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians (1996) 108(5):374-81.
47. Elenkov IJ, Chrousos GP, Wilder RL. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann N Y Acad Sci (2000) 917:94-105. doi:10.1111/j.1749-6632.2000.tb05374.x.
48. Maestroni GJ. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and the development. J Neuroimmunol (2002) 129(1-2):106-14. doi:10.1016/S0165-5728(02)00188-1.
49. Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K, et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol (2002) 168(12):6128-35.
50. Yanagawa Y, Matsumoto M, Togashi H. Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol (2010) 185(10):5762-8. doi:10.4049/jimmunol.1001899.
51. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev (2004) 84(1):277-359. doi:10.1152/physrev.00015.2003.
52. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. The adaptive value of fever. Infect Dis Clin North Am (1996) 10(1):1-20. doi:10.1016/S0891-5520(05)70282-8.
53. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science (1975) 188(4184):166-8. doi:10.1126/science.1114347.
54. Hasday JD, Fairchild KD, Shanholtz C. The role of fever in the infected host. Microbes Infect (2000) 2(15):1891-904. doi:10.1016/S1286-4579(00)01337-X.
55. Kokolus KM, Capitano ML, Lee CT, Eng JW, Waight JD, Hylander BL, et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci U S A (2013) 110(50)20176-81. doi:10.1073/pnas.1304291110.
56. Singh IS, Hasday JD. Fever, hyperthermia and the heat shock response. Int J Hyperthermia (2013) 29(5):423-35. doi:10.3109/02656736.2013.808766.
57. Gordon CJ. Temperature Regulation in Laboratory Rodents. Cambridge: Cambridge University Press (1993).
58. Dinarello CA. Review: infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res (2004) 10(4):201-22. doi:10.1177/09680519040100040301.
59. Ostberg JR, Kabingu E, Repasky EA. Thermal regulation of dendritic cell activation and migration from skin explants. Int J Hyperthermia (2003) 19(5):520-33. doi:10.1080/02656730310001607986.
60. Knippertz I, Stein MF, Dorrie J, Schaft N, Muller I, Deinzer A, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia (2011) 27(6):591-603. doi:10.3109/02656736.2011.589234.
61. Joshi N, Duhan V, Lingwal N, Bhaskar S, Upadhyay P. Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells. PLoS One (2012) 7(2):e32067. doi:10.1371/journal.pone.0032067.
62. Zhang HG, Mehta K, Cohen P, Guha C. Hyperthermia on immune regulation: a temperature's story. Cancer Lett (2008) 271(2):191-204. doi:10.1016/j.canlet.2008.05.026.
63. Tournier JN, Hellmann AQ, Lesca G, Jouan A, Drouet E, Mathieu J. Fever-like thermal conditions regulate the activation of maturing dendritic cells. J Leukoc Biol (2003) 73(4):493-501. doi:10.1189/jlb.1002506.
64. Basu S, Srivastava PK. Fever-like temperature induces maturation of dendritic cells through induction of hsp90. Int Immunol (2003) 15(9):1053-61. doi:10.1093/intimm/dxg104.
65. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol (2000) 18:767-811. doi:10.1146/annurev.immunol.18.1.767.
66. Ohashi PS, DeFranco AL. Making and breaking tolerance. Curr Opin Immunol (2002) 14(6):744-59. doi:10.1016/S0952-7915(02)00406-5.
67. Zheng H, Benjamin IJ, Basu S, Li Z. Heat shock factor 1-independent activation of dendritic cells by heat shock: implication for the uncoupling of heat-mediated immunoregulation from the heat shock response. Eur J Immunol (2003) 33(6):1754-62. doi:10.1002/eji.200323687.
68. Matsumoto K, Yamamoto N, Hagiwara S, Saito M, Furue H, Shigetomi T, et al. Optimization of hyperthermia and dendritic cell immunotherapy for squamous cell carcinoma. Oncol Rep (2011) 25(6):1525-32. doi:10.3892/or.2011.1232.
69. Schildkopf P, Frey B, Ott OJ, Rubner Y, Multhoff G, Sauer R, et al. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol (2011) 101(1):109-15. doi:10.1016/j.radonc.2011.05.056.
70. Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer (2005) 116(4):624-33. doi:10.1002/ijc.21061.
71. Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, et al. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma. J Biosci Bioeng (2005) 100(1):112-5. doi:10.1263/jbb.100.112.
72. Liu Q, Zhai B, Yang W, Yu LX, Dong W, He YQ, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther (2009) 17(12):2049-57. doi:10.1038/mt.2009.221.
73. Schueller G, Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Benkoe T, et al. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int J Oncol (2003) 22(6):1397-402.
74. Mukhopadhaya A, Mendecki J, Dong X, Liu L, Kalnicki S, Garg M, et al. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res (2007) 67(16):7798-806. doi:10.1158/0008-5472.CAN-07-0203.
75. Ostberg JR, Taylor SL, Baumann H, Repasky EA. Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J Leukoc Biol (2000) 68(6):815-20.
76. Shi H, Cao T, Connolly JE, Monnet L, Bennett L, Chapel S, et al. Hyperthermia enhances CTL cross-priming. J Immunol (2006) 176(4):2134-41.
77. Wang Y, Seidl T, Whittall T, Babaahmady K, Lehner T. Stress-activated dendritic cells interact with CD4+ T cells to elicit homeostatic memory. Eur J Immunol (2010) 40(6):1628-38. doi:10.1002/eji.200940251.
78. Gordon CJ. Thermal physiology of laboratory mice: defining thermoneutrality. J Therm Biol (2012) 37:654-85. doi:10.1016/j.jtherbio.2012.08.004.
79. Karp CL. Unstressing intemperate models: how cold stress undermines mouse modeling. J Exp Med (2012) 209(6):1069-74. doi:10.1084/jem.20120988.
80. Overton JM. Phenotyping small animals as models for the human metabolic syndrome: thermoneutrality matters. Int J Obes (2010) 34(Suppl 2):S53-8. doi:10.1038/ijo.2010.240.
81. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab (2009) 9(2):203-9. doi:10.1016/j.cmet.2008.12.014.
82. Shimizu I, Iida T, Guan Y, Zhao C, Raja SN, Jarvis MF, et al. Enhanced thermal avoidance in mice lacking the ATP receptor P2X3. Pain (2005) 116(1-2):96-108. doi:10.1016/j.pain.2005.03.030.
83. Gordon CJ, Becker P, Ali J. Behavioral thermoregulatory responses of single-and group-housed mice. Physiol Behav (1998) 65(2):255-62. doi:10.1016/S0031-9384(98)00148-6.
84. Uchida K, Shiuchi T, Inada H, Minokoshi Y, Tominaga M. Metabolic adaptation of mice in a cool environment. Pflugers Arch (2010) 459(5):765-74. doi:10.1007/s00424-010-0795-3.
85. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature (2011) 480(7375):104-8. doi:10.1038/nature10653.
86. Virtue S, Even P, Vidal-Puig A. Below thermoneutrality, changes in activity do not drive changes in total daily energy expenditure between groups of mice. Cell Metab (2012) 16(5):665-71. doi:10.1016/j.cmet.2012.10.008.
87. Ravussin Y, LeDuc CA, Watanabe K, Leibel RL. Effects of ambient temperature on adaptive thermogenesis during maintenance of reduced body weight in mice. Am J Physiol Regul Integr Comp Physiol (2012) 303(4):R438-48. doi:10.1152/ajpregu.00092.2012.
88. Serrat MA, King D, Lovejoy CO. Temperature regulates limb length in homeotherms by directly modulating cartilage growth. Proc Natl Acad Sci U S A (2008) 105(49):19348-53. doi:10.1073/pnas.0803319105.
89. Swoap SJ, Li C, Wess J, Parsons AD, Williams TD, Overton JM. Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. Am J Physiol Heart Circ Physiol (2008) 294(4):H1581-8. doi:10.1152/ajpheart.01000.2007.
90. Lo Martire V, Silvani A, Bastianini S, Berteotti C, Zoccoli G. Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons. PLoS One (2012) 7(10):e47032. doi:10.1371/journal.pone.0047032.
91. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res (2000) 6(5):1755-66.
92. Gill MA, Bajwa G, George TA, Dong CC, Dougherty II, Jiang N, et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol (2010) 184(11):5999-6006. doi:10.4049/jimmunol.0901194.
93. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell LE, et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature (2003) 424(6946):324-8. doi:10.1038/nature01783.
94. O'Keeffe M, Fancke B, Suter M, Ramm G, Clark J, Wu L, et al. Nonplasmacytoid, high IFN-alpha-producing, bone marrow dendritic cells. J Immunol (2012) 188(8):3774-83. doi:10.4049/jimmunol.1101365.
95. Voisine C, Mastelic B, Sponaas AM, Langhorne J. Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int J Parasitol (2010) 40(6):711-9. doi:10.1016/j.ijpara.2009.11.005.
96. Lin ML, Zhan Y, Proietto AI, Prato S, Wu L, Heath WR, et al. Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci U S A (2008) 105(8):3029-34. doi:10.1073/pnas.0712394105.
97. Edelson BT, Bradstreet TR, Hildner K, Carrero JA, Frederick KE, KC W, et al. CD8alpha(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. Immunity (2011) 35(2):236-48. doi:10.1016/j.immuni.2011.06.012.
98. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol (2000) 164(6):2978-86.
99. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science (2008) 322(5904):1097-100. doi:10.1126/science.1164206.
100. Hurwitz AA, Watkins SK. Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother (2012) 61(2):289-93. doi:10.1007/s00262-011-1181-5.
101. Watkins SK, Hurwitz AA. FOXO3: a master switch for regulating tolerance and immunity in dendritic cells. Oncoimmunology (2012) 1(2):252-4. doi:10.4161/onci.1.2.18241.
102. Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, et al. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest (2011) 121(4):1361-72. doi:10.1172/JCI44325.
103. Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, et al. Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res (2009) 69(15):6256-64. doi:10.1158/0008-5472.CAN-08-4516.